Sara Nik

Stock Analyst at HC Wainwright & Co.

(n/a)

# 4,872

Out of 5,139 analysts

4

Total ratings

n/a

Success rate

-40.87%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sara Nik

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MBRX Moleculin Biotech	Maintains: Buy	$4 → $22	$4.16	+428.85%	3	Dec 11, 2025
	KTTA Pasithea Therapeutics	Initiates: Buy	$3	$0.93	+224.08%	1	Dec 8, 2025

Moleculin Biotech

Dec 11, 2025

Maintains: Buy

Price Target: $4 → $22

Current: $4.16

Upside: +428.85%

Pasithea Therapeutics

Dec 8, 2025

Initiates: Buy

Price Target: $3

Current: $0.93

Upside: +224.08%